Back to companies

Bristol-Myers Squibb Co: Overview

Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that is engaged in discovery, development, licensing and manufacturing, marketing, distribution and sale of medicines and related medical products to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology and fibrotic therapeutic projects. The company offers its products across the world to wholesalers, retail pharmacies, hospitals, medical professionals and government entities. BMS provides its products in the US, Europe, and Japan. The company conducts research to focus on the discovery and development of novel medicines that address serious diseases in areas of significant unmet medical need. BMS is headquartered in New York City, New York, the US.

Headquarters United States of America

Address 430 E 29th St Fl 14, 345 Park Ave, New York, 10154


Telephone 1 212 5464000

No of Employees 32,200

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange BMY (NYSE)

Revenue (2021) $46.4B 9.1% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX 177.6% (2021 vs 2020)

Market Cap* $163.0B

Net Profit Margin (2021) XXX 171.1% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

4,200+

Clinical Trials

Determine Bristol-Myers Squibb Co go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

2,000+

Catalyst Calendar

Proactively evaluate Bristol-Myers Squibb Co’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1,000+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1,000+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Bristol-Myers Squibb Co’s relevant decision makers and contact details.

730+

Pipeline Drugs

Identify which of Bristol-Myers Squibb Co’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

270+

Marketed Drugs

Understand Bristol-Myers Squibb Co’s commercialized product portfolio to stay one step ahead of the market.

160+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

120+

Consumer Market Data Insights

Insight into market share and brand performance.

110+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Bristol-Myers Squibb Co and assess market opportunity for new entrants with patient population 8-year forecasts.

40+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

40+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

11+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

5

Investigators

Review investigator profiles and find information on trial contacts across Bristol-Myers Squibb Co, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Cardiovascular Drugs Abecma
Virology Drugs Abraxane
Immunoscience Drugs Azactam
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Financing Agreements In June, the company invested US$80 million in Owkin, AI biotech startup.
2022 Others In June, the company announced three-year data from phase 3 CheckMate -9LA trial demonstrate long-term, durable survival outcomes of Opdivo (nivolumab) Plus Yervoy (ipilimumab) with two cycles of chemotherapy for patients with Metastatic non-small cell lung cancer.
2022 Others In June, the company announced five-year results from Part 1 of the Phase 3 CheckMate -227 trial.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Bristol-Myers Squibb Co Johnson & Johnson Novartis AG Merck & Co Inc GSK plc
Headquarters United States of America United States of America Switzerland United States of America United Kingdom
City New York New Brunswick Basel Whitehouse Station Brentford
State/Province New York New Jersey - New Jersey -
No. of Employees 32,200 141,700 110,000 68,000 90,096
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Giovanni Caforio, M.D. Chief Executive Officer; Chairman Executive Board 2017 57
David V. Elkins Executive Vice President; Chief Financial Officer Senior Management 2019 53
Paul von Autenried Chief Information Officer; Executive Vice President Senior Management 2019 60
Greg Meyers Chief Digital and Technology Officer; Executive Vice President Senior Management 2018 49
Catalina Vargas Chief of Staff to the Chief Executive Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer